论文部分内容阅读
目的:研究胃动力剂莫沙比利和抑酸剂法莫替丁对反流性食管炎(RE)的治疗效果。方法:60例病人随机分为例数相等的莫沙比利+法莫替丁组和莫沙比利组。比较两组的疗效。结果:治疗4周后,法莫替丁+莫沙比利组的临床治愈率达90％。结论:法莫替丁片+莫沙比利的治疗效果优于莫沙比利。
Objective: To study the therapeutic effect of Mosapride and antacid famotidine on reflux esophagitis (RE). Methods: Sixty patients were randomly divided into two groups: mosapride + famotidine group and mosapride group. Compare the curative effect of two groups. Results: After 4 weeks of treatment, the clinical cure rate of famotidine + mosapride group was 90%. Conclusions: The efficacy of famotidine tablets + mosapride is superior to mosapride.